[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kubasiak, 2002 - Google Patents

Apoptotic signaling pathways in hypoxia-acidosis and hypoxia-reoxygenation of cardiac myocytes

Kubasiak, 2002

Document ID
1459673214594718256
Author
Kubasiak L
Publication year

External Links

Snippet

Over 15 million people in the world die each year due to cardiovascular diseases. Many forms of these heart diseases are correlated with substantial loss of the myocardium. Apoptosis or programmed cell death is considered to play a major role in the cell death …
Continue reading at search.proquest.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use

Similar Documents

Publication Publication Date Title
Xiang et al. Bax involvement in p53-mediated neuronal cell death
Klein et al. The harlequin mouse mutation downregulates apoptosis-inducing factor
Kiechle et al. Apoptosis: biochemical aspects and clinical implications
Crompton Mitochondrial intermembrane junctional complexes and their role in cell death
Braddock et al. Intron-less RNA injected into the nucleus of Xenopus oocytes accesses a regulated translation control pathway
EP0921821B1 (en) 2-methoxyestradiol-induced apoptosis in cancer cells
US20090258794A1 (en) Apoptosis methods, genes and proteins
JP2011103892A (en) Nucleic acid, polypeptide, and method for modulating apoptosis
Ozawa Oxidative damage and fragmentation of mitochondrial DNA in cellular apoptosis
Chowdhury et al. Prohibitin (PHB) acts as a potent survival factor against ceramide induced apoptosis in rat granulosa cells
KR20050007383A (en) Nucleic acids, polypeptides, and methods for modulating apoptosis
US20030125265A1 (en) Anti-estrogen receptor agents for chemotherapy
Ross et al. BCLW mediates survival of postmitotic Sertoli cells by regulating BAX activity
US7381708B2 (en) Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye
Kubasiak Apoptotic signaling pathways in hypoxia-acidosis and hypoxia-reoxygenation of cardiac myocytes
KR20050046015A (en) Nucleic acids, polypeptides, and methods for modulating apoptosis
Malladi et al. Deletion mutational analysis of BMRP, a pro-apoptotic protein that binds to Bcl-2
US20020052332A1 (en) Methods of inhibiting retinal pigment epithelial cell degeneration, stable cell lines, and uses
Mott Mitochondrial pore dysfunction, a novel mechanism for age-related disease
JP2003040801A (en) New use of neuron calcium sensor-1(ncs-1) in treatment of cns disturbance and development of treating medicine
Shammas Mitochondrial Dysfunction and Stress Responses in CHCHD10 Myopathy and Neurodegeneration
Pias Oxidant and redox-dependent apoptosis and the role of SOD-overexpression in a PC12 cell model
Ens Molecular mechanisms of E1A-induced apoptosis in the heart
Williams Identification of a protective role for mitochondrial deoxyuridine triphosphate nucleotidohydrolase against oxidative stress-induced apoptosis in mouse myoblasts
Liu et al. The effects of αB-crystallin on mitochondrial death pathway during hydrogen peroxide induced apoptosis